Resources
-
Streamlining Agile MS Workflows
with Genedata
Speaker Presentation: Mass Spec 2025
Cazy Aaron, Eli Lilly and Company, 2025 -
New Paradigm for Charge Variant Characterization Utilizing 'Discovery' Assisted Fractionation Strategy
Speaker Presentation: Mass Spec 2025
Xiao Yongsheng, WuXi Biologics, 2025 -
Mechanistic Insights into non-mAb Aggregation Using MS-Cleavable Linker
Speaker Presentation: Mass Spec 2025
Whitty-Léveillé Laurence, Merck & Co., Inc., 2025 -
Applications of Mass Spectrometry in Biopharmaceutical Discovery: From Small Molecules to Proteins
Speaker Presentation: Mass Spec 2025
Sahasrabuddhe Aniruddha, Amgen Inc., 2025 -
Automation and HTP Mass Spectrometry to Accelerate Biotherapeutics Discovery
Speaker Presentation: Mass Spec 2025
Pomerantz Steven C, Johnson & Johnson, 2025 -
Diving Into the Complexities of Non-Natural Amino Acid Antibodies with Innovating Mass Spectrometry Approaches
Speaker Presentation: Mass Spec 2025
Nanda Hirsh, Johnson & Johnson, 2025 -
A Robust and Versatile New Peak Detection Workflow to Facilitate the Implementation of the LC-MS Multi-Attribute Method (MAM) from Research to Commercialization
Speaker Presentation: Mass Spec 2025
Merkle Patrick, Novartis Pharma AG, 2025 -
Monitoring Intact AAV and AAV Building Blocks Through Individual Ion Mass Spectrometry
Speaker Presentation: Mass Spec 2025
McGee Jack, ImmPro, Inc., 2025 -
Evaluating Antigen-Antibody Interactions: A Comparative Study of Higher-Order Structural MS Methods
Speaker Presentation: Mass Spec 2025
Ma Yiran Silvia, Eli Lilly and Company, 2025 -
Leveraging Mass Spectrometry Analytical Methods in FDA Cell & Gene Therapy Regulatory Submissions: Current Uses and Future Opportunities
Speaker Presentation: Mass Spec 2025
Lucas Tiffany, ELIQUENT Life Sciences, 2025 -
Integrating Mass Spectrometry-Based Structural
Proteomics and Molecular Docking to Analyze Ebola
Protein-Host Binding Interfaces
Speaker Presentation: Mass Spec 2025
Kuang Xinyi Cynthia, Washington University in St. Louis, 2025 -
LCMS Assays for mRNA CQAs: A Development Story
Speaker Presentation: Mass Spec 2025
Johnson Alex, Aldevron, LLC, 2025 -
Unraveling the Metabolic Regulatory Mechanisms Driving Product Expression and Quality in CHO Cell Cultures Using a Multi-Omics Approach
Speaker Presentation: Mass Spec 2025
Gorre Elsa, Johnson & Johnson, 2025 -
Employing Electron Activated Dissociation (EAD) fragmentation to identify reactive N-oxide impurities in Lipid Nanoparticles (LNPs)
Speaker Presentation: Mass Spec 2025
Crowe Adam, Cytiva, 2025 -
Rapid Online Buffer Exchange with the DynaChip X1 Platform for Complex Biological Analysis
Speaker Presentation: Mass Spec 2025
Chilmonczyk Mason, Andson Biotech, 2025 -
Expanding MAM Horizon Beyond mAb-Based Therapeutics
Speaker Presentation: Mass Spec 2025
Carillo Sara, NIBRT, 2025 -
New Mass Spec Methods to Tackle New Biotherapeutic Challenges
Roundtable Notes: Session 1 Table 1 Mass Spec 2025
New Mass Spec Methods to Tackle New Biotherapeutic Challenges -
MS-Based Protein Higher Order Structure Characterization in Biologics Research and Development
Roundtable Notes: Session 1 Table 2 Mass Spec 2025
MS-Based Protein Higher Order Structure Characterization in Biologics Research and Development -
MS of RNA and Oligonucleotides - Characterization and Quantitation of CQAs
Roundtable Notes: Session 1 Table 3 Mass Spec 2025
MS of RNA and Oligonucleotides - Characterization and Quantitation of CQAs -
MS for HCP
Roundtable Notes: Session 1 Table 6 Mass Spec 2025
MS for HCP